Noninvasive Brain Stimulation for Fibromyalgia

This trial investigates whether noninvasive brain stimulation (NIBS) can reduce pain and improve the quality of life for individuals with fibromyalgia, a condition causing widespread pain and fatigue. Participants will undergo repeated sessions targeting different brain areas, including Occipital Lobe Stimulation and Primary Motor Cortex Stimulation, to determine the most effective approach. The study seeks individuals diagnosed with fibromyalgia who experience ongoing pain not relieved by standard pain medications and have had this pain for more than three months. As an unphased trial, this study offers a unique opportunity to explore innovative treatments that could potentially enhance quality of life.

Research shows that stimulating the occipital lobe and the primary motor cortex is generally safe for treating fibromyalgia.

For occipital lobe stimulation, studies have found it can significantly reduce pain for people with fibromyalgia. One study reported a 39.74% decrease in pain intensity on a visual scale, with no serious side effects, indicating the treatment is well-tolerated.

Researchers have also examined primary motor cortex stimulation for safety and effectiveness. Studies show it can lower pain scores without major side effects. Some research notes improvements in overall fibromyalgia symptoms with this treatment.

Unlike traditional treatments for fibromyalgia, such as medications and physical therapy, these new approaches use noninvasive brain stimulation. Researchers are excited about targeting the brain itself by stimulating the occipital lobe and primary motor cortex, which could offer relief without the side effects of drugs. This method directly influences brain activity, potentially providing faster and more effective pain relief. By using this innovative technique, scientists aim to uncover new ways to manage fibromyalgia symptoms that go beyond the limitations of existing options.

Research has shown that stimulating the primary motor cortex can help reduce pain in people with chronic pain and fibromyalgia. Studies have found that this method leads to noticeable drops in pain levels and improved quality of life, with more than half of the patients experiencing less pain after several sessions. In this trial, one group will receive Primary Motor Cortex Stimulation followed by Occipital Lobe Stimulation.